Hypothesis: Iodine, selenium and the development of breast cancer

被引:66
作者
Cann, SA
van Netten, JP
van Netten, C
机构
[1] Royal Jubilee Hosp, Special Dev Lab, Victoria, BC V8R 1J8, Canada
[2] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada
[3] Univ British Columbia, Fac Med, Dept Hlth Care & Epidemiol, Vancouver, BC, Canada
关键词
breast neoplasms; iodine; selenium; thyroid diseases;
D O I
10.1023/A:1008925301459
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In this paper we examine some of the evidence linking iodine and selenium to breast cancer development. Seaweed is a popular dietary component in Japan and a rich source of both of these essential elements. We hypothesize that this dietary preference may be associated with the low incidence of benign and malignant breast disease in Japanese women. In animal and human studies, iodine administration has been shown to cause regression of both iodine-deficient goiter and benign pathological breast tissue. Iodine, in addition to its incorporation into thyroid hormones, is organified into anti-proliferative iodolipids in the thyroid; such compounds may also play a role in the proliferative control of extrathyroidal tissues. Selenium acts synergistically with iodine. All three mono-deiodinase enzymes are selenium-dependent and are involved in thyroid hormone regulation. In this way selenium status may affect both thyroid hormone homeostasis and iodine availability. Conclusion: Although there is suggestive evidence for a preventive role for iodine and selenium in breast cancer, rigorous retrospective and prospective studies are needed to confirm this hypothesis.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 102 条
[61]   SELENIUM IN HUMAN MAMMARY CARCINOGENESIS - A CASE-COHORT STUDY [J].
OVERVAD, K ;
WANG, DY ;
OLSEN, J ;
ALLEN, DS ;
THORLING, EB ;
BULBROOK, RD ;
HAYWARD, JL .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (07) :900-902
[62]  
Overvad K, 1991, Eur J Cancer Prev, V1, P27, DOI 10.1097/00008469-199110000-00005
[63]   Cancer statistics, 1997 [J].
Parker, SL ;
Tong, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1997, 47 (01) :5-27
[64]  
Pennington JAT, 1996, INT J VITAM NUTR RES, V66, P350
[65]  
PETERS F, 1985, CANCER, V56, P1082, DOI 10.1002/1097-0142(19850901)56:5<1082::AID-CNCR2820560520>3.0.CO
[66]  
2-O
[67]   STUDIES ON THE GOITER INHIBITING ACTION OF IODOLACTONES [J].
PISAREV, MA ;
KRAWIEC, L ;
JUVENAL, GJ ;
BOCANERA, LV ;
PREGLIASCO, LB ;
SARTORIO, G ;
CHESTER, HA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 258 (1-2) :33-37
[68]   CYCLICAL MASTALGIA AS A MARKER OF BREAST-CANCER SUSCEPTIBILITY - RESULTS OF A CASE-CONTROL STUDY AMONG FRENCH WOMEN [J].
PLUBUREAU, G ;
THALABARD, JC ;
SITRUKWARE, R ;
ASSELAIN, B ;
MAUVAISJARVIS, P .
BRITISH JOURNAL OF CANCER, 1992, 65 (06) :945-949
[70]  
ROSS RK, 1994, NEW ENGL J MED, V330, P1683